Back to Supplement Finder

NAD+ X 500mg

Sold by FMI Health

INR 15,524.00

View at FMI Health
Store
fmihealth.com
Brand
Biolongevity Labs
Product type
Peptides
Collected
2026-11-20

From the retailer

Retailer description retrieved 2026-11-20. Claims are the retailer’s, not independently verified.

Description--NAD+ (Nicotinamide Adenine Dinucleotide)

NAD+ is a crucial coenzyme present in all living cells, central to redox reactions and cellular metabolism. It participates in glycolysis, β‑oxidation, and oxidative phosphorylation, while also serving as a substrate for post‑translational modifications such as ADP‑ribosylation and deacetylation. These processes are vital for energy metabolism, DNA repair, gene expression, and stress response. Beyond its metabolic role, NAD+ functions as a signaling molecule, influencing pathways related to cell survival, aging, and disease susceptibility. Levels of NAD+ decline with age, sparking interest in NAD+‑boosting molecules for health and longevity.

 

Mechanistic Claims

  • Energy Metabolism: Essential cofactor in glycolysis, β‑oxidation, and oxidative phosphorylation.
  • DNA Repair & Genomic Stability: Substrate for PARPs (poly‑ADP ribose polymerases) involved in DNA repair.
  • Epigenetic Regulation: Supports sirtuin‑mediated deacetylation, modulating gene expression and stress resistance.
  • Cell Survival & Stress Response: Influences pathways that regulate apoptosis, inflammation, and cellular resilience.
  • Aging & Longevity: Declining NAD+ levels linked to metabolic dysfunction, mitochondrial decline, and age‑related diseases.

 

Research Applications

  • Metabolic and mitochondrial biology studies
  • DNA repair and genomic stability investigations
  • Epigenetics and sirtuin biology research
  • Aging and longevity studies
  • Neurodegenerative and age‑related disease models

 

NAD+ Research

NAD+ is involved in redox reactions and serves as a cofactor for various enzymes, including sirtuins and poly(ADP-ribose) polymerases. It plays a significant role in cellular processes such as metabolism, DNA repair, and chromatin remodeling, which are vital for maintaining tissue and metabolic homeostasis. A decline in NAD+ levels is observed with aging, contributing to age-associated diseases like cognitive decline, cancer, and metabolic disorders.

 

Aging and Longevity

NAD+ plays a significant role in aging and longevity. Research indicates that restoring NAD+ levels in aged or diseased animals can promote health and extend lifespan. This has led to the exploration of NAD+ precursors like nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN), which have shown promise in ameliorating age-associated 

CD38, an NADase, plays a central role in age-related NAD+ decline. Inhibiting CD38 with specific inhibitors like 78c has been shown to reverse NAD+ decline and improve metabolic and physiological parameters in aging models. This includes enhanced glucose tolerance, muscle function, and cardiac performance. The increase in NAD+ levels activates pro-longevity factors such as sirtuins and AMPK, while inhibiting pathways like mTOR-S6K that negatively affect healthspan. This pharmacological strategy highlights the potential of targeting NAD+ metabolism to prevent or reverse age-related metabolic 

 

Metabolic Disorders

Alterations in NAD+ metabolism are closely linked to the development of metabolic disorders such as diabetes, obesity, and non-alcoholic fatty liver disease (NAFLD). NAD+ levels tend to decrease with aging and under conditions of nutrient disturbance, contributing to these 

 

Cardiovascular Diseases

Aging and metabolic stress are associated with a decline in NAD+ levels, which can lead to mitochondrial dysfunction and increased susceptibility to cardiovascular 

 

Neurodegenerative Disorders

NAD+ participates in redox reactions and NAD+-dependent signaling processes, which are essential for modulating mitochondrial function and reducing oxidative stress, a common feature in neurodegenerative diseases. The activation of NAD+-dependent pathways can enhance cellular resilience against oxidative damage, which is crucial for maintaining neuronal 

 

Mitochondrial Function

NAD+ metabolism is intricately linked to mitochondrial function. It acts as a substrate for sirtuins, a family of NAD+-dependent deacylases, which are key regulators of mitochondrial homeostasis. Increased NAD+ levels and sirtuin activation have been associated with improved mitochondrial function, organismal metabolism, and lifespan across various 

 

Cancer Research

Cancer cells exhibit a unique metabolic phenotype known as the Warburg effect, characterized by increased glycolysis even in the presence of oxygen, which is supported by elevated NAD+ 

 

References

  1. Rajman, L., Chwalek, K., & Sinclair, D. (2018). Therapeutic Potential of NAD-Boosting Molecules: The In Vivo Evidence.. Cell metabolism, 27 3, 529-547 . .
  2. Tarragó, M., Chini, C., Kanamori, K., Warner, G., Caride, A., De Oliveira, G., Rud, M., Samani, A., Hein, K., Huang, R., Jurk, D., Cho, D., Boslett, J., Miller, J., Zweier, J., Passos, J., Doles, J., Becherer, D., & Chini, E. (2018). A Potent and Specific CD38 Inhibitor Ameliorates Age-Related Metabolic Dysfunction by Reversing Tissue NAD+ Decline.. Cell metabolism, 27 5, 1081-1095.e10 . .
  3. Okabe, K., Yaku, K., Tobe, K., & Nakagawa, T. (2019). Implications of altered NAD metabolism in metabolic disorders. Journal of Biomedical Science, 26. .
  4. Amjad, S., Nisar, S., Bhat, A., Shah, A., Frenneaux, M., Fakhro, K., Haris, M., Reddy, R., Patay, Z., Baur, J., & Bagga, P. (2021). Role of NAD+ in regulating cellular and metabolic signaling pathways. Molecular Metabolism, 49. .
  5. Rotllan, N., Camacho, M., Tondo, M., Diarte-Añazco, E., Canyelles, M., Méndez-Lara, K., Benítez, S., Alonso, N., Mauricio, D., Escolà-Gil, J., Blanco-Vaca, F., & Julve, J. (2021). Therapeutic Potential of Emerging NAD+-Increasing Strategies for Cardiovascular Diseases. Antioxidants, 10. .
  6. Abdellatif, M., Sedej, S., & Kroemer, G. (2021). NAD+ Metabolism in Cardiac Health, Aging, and Disease.. Circulation, 144 22, 1795-1817 . .
  7. Lin, Q., Zuo, W., Liu, Y., Wu, K., & Liu, Q. (2021). NAD+ and Cardiovascular Diseases.. Clinica chimica acta; international journal of clinical chemistry. .
  8. Pehar, M., Harlan, B., Killoy, K., & Vargas, M. (2017). Nicotinamide Adenine Dinucleotide Metabolism and Neurodegeneration.. Antioxidants & redox signaling, 28 18, 1652-1668 . .
  9. Alexandris, A., & Koliatsos, V. (2023). NAD+, Axonal Maintenance, and Neurological Disease. Antioxidants & Redox Signaling, 39, 1167 – 1184. .
  10. Zhao, Y., Zhang, J., Zheng, Y., Zhang, Y., Zhang, X., Wang, H., Du, Y., Guan, J., Wang, X., & Fu, J. (2021). NAD+ improves cognitive function and reduces neuroinflammation by ameliorating mitochondrial damage and decreasing ROS production in chronic cerebral hypoperfusion models through Sirt1/PGC-1α pathway. Journal of Neuroinflammation, 18. .
  11. Katsyuba, E., Mottis, A., Ziętak, M., De Franco, F., Van Der Velpen, V., Gariani, K., Ryu, D., Cialabrini, L., Matilainen, O., Liscio, P., Giacchè, N., Stokar-Regenscheit, N., Legouis, D., De Seigneux, S., Ivanisevic, J., Raffaelli, N., Schoonjans, K., Pellicciari, R., & Auwerx, J. (2018). De novo NAD+ synthesis enhances mitochondrial function and improves health. Nature, 563, 354 – 359. .
  12. Luongo, T., Eller, J., Lu, M., Niere, M., Raith, F., Raith, F., Perry, C., Bornstein, M., Oliphint, P., Wang, L., McReynolds, M., Migaud, M., Rabinowitz, J., Johnson, F., Johnsson, K., Johnsson, K., Ziegler, M., Cambronne, X., & Baur, J. (2020). SLC25A51 is a mammalian mitochondrial NAD+ transporter. Nature, 588, 174 – 179. .
  13. Yaku, K., Okabe, K., Hikosaka, K., & Nakagawa, T. (2018). NAD Metabolism in Cancer Therapeutics. Frontiers in Oncology, 8. .
  14. Kennedy, B., Sharif, T., Martell, E., Dai, C., Kim, Y., Lee, P., & Gujar, S. (2016). NAD+ salvage pathway in cancer metabolism and therapy.. Pharmacological research, 114, 274-283 . .
  15. Audrito, V., Managò, A., Gaudino, F., Sorci, L., Messana, V., Raffaelli, N., & Deaglio, S. (2019). NAD-Biosynthetic and Consuming Enzymes as Central Players of Metabolic Regulation of Innate and Adaptive Immune Responses in Cancer. Frontiers in Immunology, 10. .
  16. Myong, S., Nguyen, A., & Challa, S. (2024). Biological Functions and Therapeutic Potential of NAD+ Metabolism in Gynecological Cancers. Cancers, 16. .
  17. Ghanem, M., Caffa, I., Monacelli, F., & Nencioni, A. (2024). Inhibitors of NAD+ Production in Cancer Treatment: State of the Art and Perspectives. International Journal of Molecular Sciences, 25. .



Label--Product Information

Property Value
Presentation Vial
Molecular Formula C21H27N7O14P2
Molecular Weight 663.43 g/mol
CAS Number 53-84-9
PubChem CID 925
Synonyms 53-84-9, beta-nicotinamide adenine dinucleotide, Endopride, alpha-Diphosphopyridine nucleotide, 7298-93-3

 

NAD+ Structure

Source: 

Dosage--This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY.